Weight Loss · GLP-1 Side Effects · Brandon, FL
GLP-1 Side Effects
and How We Manage Them
Most GLP-1 side effects are mild, temporary, and manageable, especially with slow dosing and provider support. Here is what to expect, how to reduce them, and the rare risks we screen for.
Common GLP-1 side effects, and why they happen
Because GLP-1 medications slow digestion and reduce appetite, most side effects are gastrointestinal. They are usually mild to moderate and ease as your body adjusts.
Side effects are most noticeable when you start the medication or step up to a higher dose, which is exactly why we titrate slowly. The goal is a dose that delivers results while staying comfortable. The vast majority of patients move through the early weeks and settle in well with simple adjustments and provider support.
Most common (and usually temporary)
- Nausea
- Constipation
- Diarrhea
- Reduced appetite and early fullness
- Mild fatigue or headache
- Burping or reflux
Rare but serious, what we screen for
- Pancreatitis (severe, persistent abdominal pain)
- Gallbladder problems
- Dehydration-related kidney strain
- A boxed warning for thyroid C-cell tumors; not used with a personal or family history of medullary thyroid carcinoma or MEN2
Your provider reviews your history for these risks before prescribing and monitors you throughout. If anything concerning appears, we adjust or stop the medication.
How we keep side effects manageable
GLP-1 Side Effects, Frequently Asked Questions
Curious about cost? Your cost depends on the option that fits your case, which we map out at your consultation. The treatment you’re interested in might be on sale this month, so see our pricing page for current rates and check this month’s specials.
This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider about your specific situation.
Clinical References
- WEGOVY (semaglutide) injection, prescribing information. U.S. National Library of Medicine, DailyMed. Boxed warning for thyroid C-cell tumours observed in rodents; contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZEPBOUND (tirzepatide) injection, prescribing information. U.S. National Library of Medicine, DailyMed. Boxed warning for thyroid C-cell tumours observed in rodents; contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. Covers adverse-event reports linked to compounded products, counterfeit medication, and buying from unverified sources.
Prescribing information is provided for educational context and is not a complete list of risks. It does not constitute medical advice. Review the full label and your history with your provider.
Have Questions?
Talk through the side effects with a provider
A medical provider will review your history, explain what to expect, and build a titration plan that keeps you comfortable. Schedule your complimentary consultation.
Stay in the loop
Get the latest treatments, provider tips, and news from Florida Aesthetics & Wellness delivered to your inbox.